Latest

blood tests

Brain Cancer Featured Genetics Neurology Neuroscience

·April 24, 2025·5 min read

Blood Test Tracks Brain Tumor Growth with Patient-Specific DNA Markers

Researchers have developed a personalized blood test that may offer a faster, less invasive way to track high-grade glioma progression. By identifying unique DNA junctions from each patient's tumor, the test can detect tumor DNA in the bloodstream, even before changes appear on MRI scans.

This shows a researcher holding a card with blood on it, a brain is in the background.

Featured Neurology Neuroscience

·November 18, 2024·3 min read

Finger-Prick Test Brings Alzheimer’s Detection Closer to Everyone

A new Alzheimer’s test collects just a few drops of blood from a finger prick, which can be mailed to a lab for analysis. The test measures biomarkers like pTau217 and has shown similar accuracy to traditional venous blood sampling.

Featured Neurology Neuroscience

·September 25, 2024·5 min read

Blood Tests Uncover Lasting Damage Following Single Brain Injury

A new study reveals that moderate-to-severe traumatic brain injuries (TBI) can have long-lasting effects, persisting for decades. Using advanced MRI scans, blood biomarkers, and cognitive tests, researchers found that survivors show signs of chronic brain pathology even 22 years after their injury.

Featured Neurology Neuroscience

·July 28, 2024·8 min read

Blood Tests Revolutionize Alzheimer’s Diagnosis

New research reveals that highly accurate blood tests for Alzheimer's can improve diagnosis accuracy and expedite treatment and research participation. These tests measure biomarkers like phosphorylated tau, which correlate with cognitive decline and brain atrophy.

Featured Neurology Neuroscience

·June 18, 2024·6 min read

Blood Test Predicts Parkinson’s Years Before Symptoms

Researchers have developed an AI-powered blood test that can predict Parkinson's disease up to seven years before symptoms appear. The test analyzes eight blood biomarkers and has shown 100% accuracy in diagnosing the disease. This breakthrough offers the potential for early intervention and treatment before significant damage occurs in the brain.

Featured Neurology Neuroscience

·April 19, 2024·7 min read

Blood Test Predicts Multiple Sclerosis Years Before Symptoms Appear

Researchers identified a specific pattern of autoantibodies in the blood that precedes the clinical onset of multiple sclerosis (MS), potentially paving the way for early diagnosis and treatment. Their study found that 10% of MS patients displayed a unique set of autoantibodies against both human proteins and common pathogens like the Epstein-Barr Virus years before showing symptoms.

Featured Neurology Neuroscience

·April 5, 2024·5 min read

UK to Begin Nationwide Blood Test Trials for Dementia

The UK is set to conduct nationwide trials to evaluate the effectiveness of blood tests in diagnosing dementia. The Blood Biomarker Challenge aims to validate potential blood tests for clinical use in the NHS within five years.

Featured Neuroscience Psychology

·February 8, 2024·5 min read

New Blood Test Breakthrough for Schizophrenia Management

Researchers developed a groundbreaking blood test capable of measuring the severity and risk of schizophrenia, fundamentally changing the approach to diagnosing and treating this complex psychiatric disorder. The test identifies specific biomarkers that not only predict the condition's progression but also facilitate personalized treatment plans.

Featured Neuroscience Open Neuroscience Articles Psychology

·March 7, 2023·4 min read

Blood Test for Anxiety Developed

A newly developed blood test screens for biomarkers associated with anxiety to determine a person's risk of developing the disorder as well as monitor the severity of symptoms in those with anxiety.

Brain Cancer Featured Neurology Neuroscience

·February 27, 2023·5 min read

Blood Test for Brain Cancer May Be on Horizon

A new blood-based test to screen for biomarkers of glioblastoma brain cancer has been developed by researchers at Penn State. The test looks for elevated levels of IL13Rα2, an antigen receptor that is derived from glioblastoma tumors.

This shows a researcher testing a blood sample

Featured Neurology Neuroscience

·January 17, 2023·5 min read

New Blood Test Differentiates Neurodegeneration in Alzheimer’s Disease From Other Dementias

Researchers have developed a new blood test for brain-derived Tau that can follow and track the progression of Alzheimer's disease while excluding other dementias.